european: search

Biopure Corporation wins European patent challenge

Add our medical news to digg - Biopure Corporation wins European patent challenge Add our medical news to NewsVine - Biopure Corporation wins European patent challenge Add our medical news to Fark - Biopure Corporation wins European patent challenge Add our medical news to Furl - Biopure Corporation wins European patent challenge Add our medical news to Shadows - Biopure Corporation wins European patent challenge Add our medical news to YahooMyWeb - Biopure Corporation wins European patent challenge Add our medical news to Reddit -Biopure Corporation wins European patent challenge Add our medical news to StumbleUpon - Biopure Corporation wins European patent challenge Add our medical news to Facebook - Biopure Corporation wins European patent challenge

Non-Disruptive Backups and Migrations Enhances European Patent Protection and Management

The European Patent Office grants European patents. The EPO carries out searches and substantive examinations on a steadily rising number of European patent applications and international applications filed under the Patent Cooperation Treaty. The European Patent Office (EPO) needed to support up to 60 million patents documents and 800,000 patents within a high availability and ultra resilient DB2 environment. The European Patent Office deployed BMC DB2 solutions to more effectively support its customers and the management of its patent applications.

EU to double its R&D investment in robotics

At the occasion of AUTOMATICA 2008, one of the leading international trade fairs in robotics and automation held this year in Munich/Germany, the European Commission has announced a policy to boost European robotics. The European Union will double its investments between 2007 and 2010 with almost € 400 million to support European robotics research. This ambitious programme aims to forge stronger links between academia and industry, and plans to fund a widespread experimentation by academic researchers and industry. The European Commission also calls on the industry to intensify its efforts in producing critical components in Europe, such as gears, in order to face competition from Asia and avoid strategic dependencies on other regions of the world.

EU to double its R&D investment in robotics

At the occasion of AUTOMATICA 2008, one of the leading international trade fairs in robotics and automation held this year in Munich/Germany, the European Commission has announced a policy to boost European robotics. The European Union will double its investments between 2007 and 2010 with almost € 400 million to support European robotics research. This ambitious programme aims to forge stronger links between academia and industry, and plans to fund a widespread experimentation by academic researchers and industry. The European Commission also calls on the industry to intensify its efforts in producing critical components in Europe, such as gears, in order to face competition from Asia and avoid strategic dependencies on other regions of the world.

European software patents via treaty?

PRESS RELEASE -- [ Europe / Economy / Innovation ] ======================================================================== McCreevy wants to legalise Software Patents via a US-EU patent treaty ======================================================================== Brussels, 13 May 2008 -- European Commissioner McCreevy is pushing for a bilateral patent treaty with the United States. This Tuesday 13 May in Brussels, White House and European representatives will try to adopt a tight roadmap for the signature of a EU-US patent treaty by the end of the year. Parts of the proposed treaty will contain provision on software patents, and could legalise them on both sides of the Atlantic. "TEC talks are the current push for software patents. The US want to eliminate the higher standards of the European Patent Convention.

Nanotechnology part of European Defence Agency's new Disruptive Defence Technologies program

(Nanowerk News) European governments agreed today to establish a new Joint Investment Programme (JIP) for research into emerging technologies which might have a disruptive effect on the battlefield, using an innovative structure devised by the European Defence Agency (EDA) to boost collaborative European efforts on defence Research & Technology.

Biopure Wins European Patent Challenge

PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it has successfully defended a challenge at the European Patent Office (EPO) to its European Patent entitled, "A Method for Chromatographic Removal of Prions." This European Patent covers Biopure's innovative purification method for removing potentially infectious prion proteins from oxygen therapeutics and provides Biopure with granted patent rights to its method in

Biopure Wins European Patent Challenge

CAMBRIDGE, Mass., May 19, 2008 /PRNewswire-FirstCall/ -- Biopure Corporation announced today that it has successfully defended a challenge at the European Patent Office (EPO) to its European Patent entitled, "A Method for Chromatographic Removal of Prions." This European Patent covers Biopure's innovative purification method for removing potentially infectious prion proteins from oxygen therapeutics and provides Biopure with granted patent rights to its method in France, Germany, the United Kingdom, Ireland, Italy, Spain, and Switzerland. The Opposition Division of the EPO supported Biopure's rights to all of the claims originally granted by the EPO without any modifications or restrictions. The patent challenge was brought in an Opposition by Switzerland-based Octapharma AG.

Biopure Wins European Patent Challenge

CAMBRIDGE, Mass., May 19 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it has successfully defended a challenge at the European Patent Office (EPO) to its European Patent entitled, "A Method for Chromatographic Removal of Prions." This European Patent covers Biopure's innovative purification method for removing potentially infectious prion proteins from oxygen therapeutics and provides Biopure with granted patent rights to its method in France, Germany, the United Kingdom, Ireland, Italy, Spain, and Switzerland. The Opposition Division of the EPO supported Biopure's rights to all of the claims originally granted by the EPO without any modifications or restrictions. The patent challenge was brought in an Opposition by Switzerland-based Octapharma AG.

Biopure Wins European Patent Challenge

CAMBRIDGE, Mass., May 19 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR - News) announced today that it has successfully defended a challenge at the European Patent Office (EPO) to its European Patent entitled, "A Method for Chromatographic Removal of Prions." This European Patent covers Biopure's innovative purification method for removing potentially infectious prion proteins from oxygen therapeutics and provides Biopure with granted patent rights to its method in France, Germany, the United Kingdom, Ireland, Italy, Spain, and Switzerland. The Opposition Division of the EPO supported Biopure's rights to all of the claims originally granted by the EPO without any modifications or restrictions. The patent challenge was brought in an Opposition by Switzerland-based Octapharma AG.

Audi engineers entitled to be European Inventor of 2008

On 6th May, the third edition of the European Inventor of the Year awards took place in Ljubljana to honour some of the continent's brightest minds as the European Inventors of the Year. Owing to the development of the company's aluminium space frames, the engineers from Audi were entitled to be European Inventors of the year 2008.

Silence Therapeutics Announces Successful Opposition of Glover Patent

a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety. The Opposition Division of the European Patent Office, following a three day hearing, announced its decision to revoke European Patent EP 1 230 375, exclusively licensed to Alnylam Pharmaceuticals from Cancer Research Technology, Ltd (UK). The Patent, commonly referred to as the "Glover" patent, broadly relates to medicaments comprising an RNA interference mediating RNA molecule. Opposition briefs to the Glover patent had been filed by Silence Therapeutics AG, Sanofi-Aventis Deutschland GmbH, Quark Biotech, Inc.

What's new in the EU: EU to double its R&D investment in robotics

At the occasion of AUTOMATICA 2008, one of the leading international trade fairs in robotics and automation held this year in Germany, the European Commission recently announced a policy to boost European robotics. The European Union said it will double its investments with almost €400 million to support European robotics research.

Best Buy Pays $2.1 Billion For Half Of Britain's Carphone Warehouse

U.S. electronics store Best Buy said today that it is paying $2.1 billion for half of Carphone Warehouse in order to enter the European consumer electronics market, Reuters reports. Carphone’s 2,400 existing stores will continue to operate under the Carphone Warehouse and Phone House brands in nine European markets, and starting in 2009 the new company will roll out larger stores under the Best Buy name. Previously, Best Buy teamed up with Carphone Warehouse to create Best Buy Mobile in the U.S. The concept will be added to all Best Buy stores this year. The two companies also have been collaborating to bring Geek Squad technical support to European markets. Best Buy said the consumer electronics category is the fastest-growing in European retail over the past five years and represents about a £89 billion ($175 billion) market.

European spacecraft to skim Martian moon

PARIS -- The European spacecraft Mars Express is to make a daring flyby of the Martian moon Phobos in the hope of gaining insights into its enigmatic surface, temperature and geological past, the European Space Agency (ESA) said on Wednesday.

European Patent Office hears dispute on human stem cells

Munich - A European Patent Office (EPO) tribunal in Munich heard a dispute Tuesday on whether a method of growing embryonal human stem cells can be patented, but gave no date for its decision on the controversial case. US scientist James Thomson, who in 1998 was the first in the world to cultivate such stem cells, is appealing to EPO's highest board over the refusal to grant a patent in the European Union for the so-called WARF stem cell.

European Inventor of the Year 2008: Audi

Audi's Space Frame (ASF) Technology has just been recognized as having made a significant contribution to Europe's economic growth and competitiveness. Praise for the technology comes from the European Patent Office, who has called Audi AG the European inventor of the year.

European Inventor of the Year 2008: Audi

Audi's Space Frame (ASF) Technology has just been recognized as having made a significant contribution to Europe's economic growth and competitiveness. Praise for the technology comes from the European Patent Office, who has called Audi AG the European inventor of the year.

At Last, A European Astronaut Program

The European Space Agency is accepting open applications for its inaugural class. Frank Danesy oversees Human Resources for the European Space Agency and is heading up the astronaut recruitment teams.

Phobic encounter: European spacecraft to skim Martian moon

PARIS (AFP) - The European spacecraft Mars Express is to make a daring flyby of the Martian moon Phobos in the hope of gaining insights into its enigmatic surface, temperature and geological past, the European Space Agency (ESA) said on Wednesday.

Avanti wins European Space Agency disaster alert system deal

LONDON (Thomson Financial) - Avanti Communications Group PLC said it has been chosen by the European Space Agency (ESA) for a 200,000 euros project to develop concepts for a European wide satellite-based alerting system.

Avanti wins European Space Agency disaster alert system deal

LONDON (Thomson Financial) - Avanti Communications Group PLC said it has been chosen by the European Space Agency (ESA) for a 200,000 euros project to develop concepts for a European wide satellite-based alerting system.

Biopure Wins European Patent Challenge

CAMBRIDGE, MASS - Biopure Corporation announced in a press release that it has successfully defended a challenge at the European Patent Office (EPO) to its European Patent entitled, "A Method for Chromatographic Removal of Prions".

immatics gets US & European patents for off-the shelf cancer vaccine

immatics biotechnologies GmbH announced that the company has obtained European patent protection for its technology platform Xpresident. In addition, the company has been granted important US and European patents covering compounds contained in its lead product candidates IMA901 and IMA910.

AUDI WINS EUROPEAN INVENTOR OF THE YEAR 2008

More than just a safety feature that helps enhance performance and save fuel, Audi's Space Frame (ASF) Technology has just been recognized as having made a significant contribution to Europe's economic growth and competitiveness. Praise for the technology comes this time from the European Patent Office, who has called Audi AG the European inventor of the year. The award comes as part of a contest which is intended to further Europe's image as a 'Continent of Inventors'.

Search took 0.07 seconds.